Thyroid Hormone Activation Regulates the Crosstalk between Breast Cancer and Mesenchymal Stem Cells

Background: Thyroid Hormones (THs) critically impact human cancer. Although endowed with both tumor-promoting and inhibiting effects in different cancer types, excess of THs has been linked to enhanced tumor growth and progression. Breast cancer depends on the interaction between...

Full description

Saved in:
Bibliographic Details
Main Authors: Annarita Nappi, Vittoria D’Esposito, Caterina Miro, Alessia Parascandolo, Annunziata Gaetana Cicatiello, Serena Sagliocchi, Lucia Acampora, Sepehr Torabinejad, Federica Restolfer, Maddalena Raia, Melania Murolo, Emery Di Cicco, Pietro Formisano, Monica Dentice
Format: Article
Language:English
Published: IMR Press 2025-01-01
Series:Frontiers in Bioscience-Landmark
Subjects:
Online Access:https://www.imrpress.com/journal/FBL/30/1/10.31083/FBL26113
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832586536511602688
author Annarita Nappi
Vittoria D’Esposito
Caterina Miro
Alessia Parascandolo
Annunziata Gaetana Cicatiello
Serena Sagliocchi
Lucia Acampora
Sepehr Torabinejad
Federica Restolfer
Maddalena Raia
Melania Murolo
Emery Di Cicco
Pietro Formisano
Monica Dentice
author_facet Annarita Nappi
Vittoria D’Esposito
Caterina Miro
Alessia Parascandolo
Annunziata Gaetana Cicatiello
Serena Sagliocchi
Lucia Acampora
Sepehr Torabinejad
Federica Restolfer
Maddalena Raia
Melania Murolo
Emery Di Cicco
Pietro Formisano
Monica Dentice
author_sort Annarita Nappi
collection DOAJ
description Background: Thyroid Hormones (THs) critically impact human cancer. Although endowed with both tumor-promoting and inhibiting effects in different cancer types, excess of THs has been linked to enhanced tumor growth and progression. Breast cancer depends on the interaction between bulk tumor cells and the surrounding microenvironment in which mesenchymal stem cells (MSCs) exert powerful pro-tumorigenic activities. Methods: Primary human MSCs from healthy female donors were co-cultured with DIO2 knock out (D2KO) and wild type (WT) MCF7 breast cancer cells to assess cell growth, migration, invasion and the expression of known epithelial-mesenchymal transition (EMT)- and inflammation-related markers. Furthermore, a surgery-free intraductal delivery model, i.e., the Mouse-INtraDuctal (MIND) injection method, was used as a tool for in vivo characterization of breast tumor formation and progression. Results: In this study, we uncovered a novel role of THs in regulating the tumor-stroma crosstalk. MCF7 cells enhanced the intracellular activation of THs through the TH-activating enzyme, D2, fostering their EMT properties and the dialogue with MSCs. D2 inactivation reduced the invasiveness of MCF7 cells and their responsiveness to the pro-tumorigenic induction via MSCs, both in vivo and in vitro. Conclusions: Thus, we argue that intracellular activation of THs via D2 is a critical requirement for invasive and metastatic conversion of breast cancer cells, advising the blocking of D2 as a potential therapeutic tool for cancer therapy.
format Article
id doaj-art-cd244c3e446749a7b718313f6efb3bd5
institution Kabale University
issn 2768-6701
language English
publishDate 2025-01-01
publisher IMR Press
record_format Article
series Frontiers in Bioscience-Landmark
spelling doaj-art-cd244c3e446749a7b718313f6efb3bd52025-01-25T08:55:52ZengIMR PressFrontiers in Bioscience-Landmark2768-67012025-01-013012611310.31083/FBL26113S2768-6701(24)01588-0Thyroid Hormone Activation Regulates the Crosstalk between Breast Cancer and Mesenchymal Stem CellsAnnarita Nappi0Vittoria D’Esposito1Caterina Miro2Alessia Parascandolo3Annunziata Gaetana Cicatiello4Serena Sagliocchi5Lucia Acampora6Sepehr Torabinejad7Federica Restolfer8Maddalena Raia9Melania Murolo10Emery Di Cicco11Pietro Formisano12Monica Dentice13Department of Clinical Medicine and Surgery, University of Naples “Federico II”, 80131 Naples, ItalyDepartment of Translational Medicine, University of Naples “Federico II”, 80131 Naples, ItalyDepartment of Clinical Medicine and Surgery, University of Naples “Federico II”, 80131 Naples, ItalyDepartment of Translational Medicine, University of Naples “Federico II”, 80131 Naples, ItalyDepartment of Clinical Medicine and Surgery, University of Naples “Federico II”, 80131 Naples, ItalyDepartment of Clinical Medicine and Surgery, University of Naples “Federico II”, 80131 Naples, ItalyDepartment of Clinical Medicine and Surgery, University of Naples “Federico II”, 80131 Naples, ItalyDepartment of Clinical Medicine and Surgery, University of Naples “Federico II”, 80131 Naples, ItalyDepartment of Clinical Medicine and Surgery, University of Naples “Federico II”, 80131 Naples, ItalyCEINGE – Biotecnologie Avanzate Società consortile a responsabilità limitata (S.c.a.r.l.), 80131 Naples, ItalyDepartment of Clinical Medicine and Surgery, University of Naples “Federico II”, 80131 Naples, ItalyDepartment of Clinical Medicine and Surgery, University of Naples “Federico II”, 80131 Naples, ItalyDepartment of Translational Medicine, University of Naples “Federico II”, 80131 Naples, ItalyDepartment of Clinical Medicine and Surgery, University of Naples “Federico II”, 80131 Naples, ItalyBackground: Thyroid Hormones (THs) critically impact human cancer. Although endowed with both tumor-promoting and inhibiting effects in different cancer types, excess of THs has been linked to enhanced tumor growth and progression. Breast cancer depends on the interaction between bulk tumor cells and the surrounding microenvironment in which mesenchymal stem cells (MSCs) exert powerful pro-tumorigenic activities. Methods: Primary human MSCs from healthy female donors were co-cultured with DIO2 knock out (D2KO) and wild type (WT) MCF7 breast cancer cells to assess cell growth, migration, invasion and the expression of known epithelial-mesenchymal transition (EMT)- and inflammation-related markers. Furthermore, a surgery-free intraductal delivery model, i.e., the Mouse-INtraDuctal (MIND) injection method, was used as a tool for in vivo characterization of breast tumor formation and progression. Results: In this study, we uncovered a novel role of THs in regulating the tumor-stroma crosstalk. MCF7 cells enhanced the intracellular activation of THs through the TH-activating enzyme, D2, fostering their EMT properties and the dialogue with MSCs. D2 inactivation reduced the invasiveness of MCF7 cells and their responsiveness to the pro-tumorigenic induction via MSCs, both in vivo and in vitro. Conclusions: Thus, we argue that intracellular activation of THs via D2 is a critical requirement for invasive and metastatic conversion of breast cancer cells, advising the blocking of D2 as a potential therapeutic tool for cancer therapy.https://www.imrpress.com/journal/FBL/30/1/10.31083/FBL26113thyroid hormonesdeiodinasesbreast cancermesenchymal stem cells
spellingShingle Annarita Nappi
Vittoria D’Esposito
Caterina Miro
Alessia Parascandolo
Annunziata Gaetana Cicatiello
Serena Sagliocchi
Lucia Acampora
Sepehr Torabinejad
Federica Restolfer
Maddalena Raia
Melania Murolo
Emery Di Cicco
Pietro Formisano
Monica Dentice
Thyroid Hormone Activation Regulates the Crosstalk between Breast Cancer and Mesenchymal Stem Cells
Frontiers in Bioscience-Landmark
thyroid hormones
deiodinases
breast cancer
mesenchymal stem cells
title Thyroid Hormone Activation Regulates the Crosstalk between Breast Cancer and Mesenchymal Stem Cells
title_full Thyroid Hormone Activation Regulates the Crosstalk between Breast Cancer and Mesenchymal Stem Cells
title_fullStr Thyroid Hormone Activation Regulates the Crosstalk between Breast Cancer and Mesenchymal Stem Cells
title_full_unstemmed Thyroid Hormone Activation Regulates the Crosstalk between Breast Cancer and Mesenchymal Stem Cells
title_short Thyroid Hormone Activation Regulates the Crosstalk between Breast Cancer and Mesenchymal Stem Cells
title_sort thyroid hormone activation regulates the crosstalk between breast cancer and mesenchymal stem cells
topic thyroid hormones
deiodinases
breast cancer
mesenchymal stem cells
url https://www.imrpress.com/journal/FBL/30/1/10.31083/FBL26113
work_keys_str_mv AT annaritanappi thyroidhormoneactivationregulatesthecrosstalkbetweenbreastcancerandmesenchymalstemcells
AT vittoriadesposito thyroidhormoneactivationregulatesthecrosstalkbetweenbreastcancerandmesenchymalstemcells
AT caterinamiro thyroidhormoneactivationregulatesthecrosstalkbetweenbreastcancerandmesenchymalstemcells
AT alessiaparascandolo thyroidhormoneactivationregulatesthecrosstalkbetweenbreastcancerandmesenchymalstemcells
AT annunziatagaetanacicatiello thyroidhormoneactivationregulatesthecrosstalkbetweenbreastcancerandmesenchymalstemcells
AT serenasagliocchi thyroidhormoneactivationregulatesthecrosstalkbetweenbreastcancerandmesenchymalstemcells
AT luciaacampora thyroidhormoneactivationregulatesthecrosstalkbetweenbreastcancerandmesenchymalstemcells
AT sepehrtorabinejad thyroidhormoneactivationregulatesthecrosstalkbetweenbreastcancerandmesenchymalstemcells
AT federicarestolfer thyroidhormoneactivationregulatesthecrosstalkbetweenbreastcancerandmesenchymalstemcells
AT maddalenaraia thyroidhormoneactivationregulatesthecrosstalkbetweenbreastcancerandmesenchymalstemcells
AT melaniamurolo thyroidhormoneactivationregulatesthecrosstalkbetweenbreastcancerandmesenchymalstemcells
AT emerydicicco thyroidhormoneactivationregulatesthecrosstalkbetweenbreastcancerandmesenchymalstemcells
AT pietroformisano thyroidhormoneactivationregulatesthecrosstalkbetweenbreastcancerandmesenchymalstemcells
AT monicadentice thyroidhormoneactivationregulatesthecrosstalkbetweenbreastcancerandmesenchymalstemcells